Farnum Rhonda
Insider CIK 1898490 · TBPH SVP, Comm & Medical Affairs
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 150,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 124,414 | — | $0 | 89,062 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 89,062 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 150,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 89,062 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 124,414 | — | — | 89,062 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,329 | $17.03 | $56.7K | 223,461 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 6,657 | $17.03 | $113.4K | 213,476 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,328 | $17.03 | $56.7K | 220,133 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 6,657 | $17.03 | $113.4K | 213,476 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,328 | $17.03 | $56.7K | 220,133 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,329 | $17.03 | $56.7K | 223,461 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2026-08-20 | 2026-08-24 | 5,667 | $16.95 | $96.1K | 226,790 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2026-08-20 | 2026-08-24 | 5,667 | $16.95 | $96.1K | 226,790 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 6,657 | $16.39 | $109.1K | 232,457 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 3,328 | $16.38 | $54.5K | 239,114 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 3,329 | $16.39 | $54.6K | 242,442 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2026-05-20 | 2026-05-22 | 5,678 | $16.55 | $94.0K | 245,771 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2026-04-01 | 2026-04-03 | 18,750 | — | $0 | 251,449 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-03-16 | 2026-03-18 | 15,534 | $14.00 | $217.5K | 240,465 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-03-16 | 2026-03-18 | 7,766 | $13.92 | $108.1K | 232,699 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2026-03-16 | 2026-03-18 | 7,767 | $13.92 | $108.1K | 255,999 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2026-02-20 | 2026-02-24 | 13,929 | $19.66 | $273.8K | 263,766 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-12-03 | 2025-12-05 | 15,534 | $18.75 | $291.3K | 277,695 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-12-03 | 2025-12-05 | 7,767 | $18.75 | $145.6K | 300,995 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-12-03 | 2025-12-05 | 7,766 | $18.75 | $145.6K | 293,229 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2025-11-20 | 2025-11-24 | 9,060 | $17.90 | $162.2K | 308,762 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2025-08-20 | 2025-08-22 | 9,096 | $13.39 | $121.8K | 317,822 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-07-14 | 2025-07-16 | 5,318 | $11.39 | $60.6K | 330,918 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-07-14 | 2025-07-16 | 4,000 | $11.39 | $45.6K | 326,918 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-07-14 | 2025-07-16 | 682 | $11.39 | $7.8K | 336,236 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-06-02 | 2025-06-04 | 24,000 | $11.00 | $264.0K | 336,918 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2025-05-20 | 2025-05-22 | 9,120 | $9.45 | $86.2K | 360,918 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-04-21 | 2025-04-23 | 4,000 | $9.00 | $36.0K | 370,038 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-02-28 | 2025-03-04 | 75,000 | — | $0 | 374,038 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2025-02-20 | 2025-02-24 | 15,810 | $9.66 | $152.7K | 299,038 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-02-10 | 2025-02-24 | 5,283 | — | $0 | 314,848 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 4,000 | $9.00 | $36.0K | 309,565 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2024-11-20 | 2024-11-22 | 9,178 | $9.97 | $91.5K | 313,565 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2024-11-11 | 2024-11-13 | 4,000 | $9.00 | $36.0K | 322,743 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2024-08-20 | 2024-08-22 | 9,222 | $8.22 | $75.8K | 326,743 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2024-07-10 | 2024-07-12 | 4,000 | $9.00 | $36.0K | 335,965 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2024-05-20 | 2024-05-22 | 9,268 | $9.10 | $84.3K | 339,965 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2024-04-02 | 2024-04-04 | 37,500 | — | $0 | 349,233 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2024-02-22 | 2024-02-22 | 1,254 | $8.71 | $10.9K | 311,733 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2024-02-20 | 2024-02-22 | 18,219 | $8.92 | $162.5K | 312,987 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 1,378 | $10.29 | $14.2K | 331,206 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2023-11-20 | 2023-11-22 | 7,982 | $10.37 | $82.8K | 332,584 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2023-08-22 | 2023-08-24 | 1,807 | $9.47 | $17.1K | 340,566 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2023-08-20 | 2023-08-22 | 10,460 | $9.70 | $101.5K | 342,373 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2023-06-08 | 2023-06-12 | 1,790 | $11.13 | $19.9K | 352,833 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2023-05-20 | 2023-05-23 | 5,567 | $11.21 | $62.4K | 354,623 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2023-03-09 | 2023-03-13 | 4,000 | $10.20 | $40.8K | 360,190 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-03-01 | 2023-03-03 | 75,000 | — | $0 | 364,190 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2023-02-20 | 2023-02-22 | 7,119 | $10.44 | $74.3K | 289,190 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2022-11-20 | 2022-11-22 | 23,268 | $10.85 | $252.5K | 296,309 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2022-08-19 | 2022-08-23 | 10,413 | $9.34 | $97.3K | 319,577 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2022-05-23 | 2022-05-24 | 1,081 | $8.93 | $9.7K | 329,990 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2022-05-20 | 2022-05-24 | 2,200 | $8.74 | $19.2K | 331,071 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2022-02-28 | 2022-03-02 | 2,356 | $10.16 | $23.9K | 333,271 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | F Tax w/h | 2022-02-18 | 2022-02-23 | 11,824 | $9.61 | $113.6K | 335,627 | SEC↗ |
| TBPH | A Award | 2021-12-14 | 2021-12-16 | 27,500 | — | $0 | 347,451 | SEC↗ |